Key result
Glibenclamide blocked the exercise-induced adaptation (warm-up angina) seen with placebo, while pinacidil caused a paradoxical decrease in ischemic threshold.
Why the study?
Does pharmacological modulation of ATP-sensitive potassium channels with glibenclamide or pinacidil affect the development of warm-up angina pectoris in patients with stable angina?
RCT (n=31)
Blinded
Does pharmacological modulation of ATP-sensitive potassium channels with glibenclamide or pinacidil affect the development of warm-up angina pectoris in patients with stable angina?
ATP-sensitive potassium channels appear to mediate the protective 'warm-up' phenomenon in stable angina, as their blockade with glibenclamide prevents exercise-induced ischemic adaptation.
Glibenclamide may blunt warm-up protection in stable angina; confirms K-ATP channel mediation of ischemic adaptation.
The aim of this study was to examine the effect of pharmacological modulation of the ATP-sensitive potassium channels in the development of warm-up angina pectoris. Thirty-one patients with stable angina pectoris, a positive exercise test and angiographically documented coronary artery disease underwent three exercise tests 90 min after receiving either glibenclamide 10.5 mg (an ATP-sensitive potassium channel blocker), pinacidil 25 mg (an ATP-sensitive potassium channel opener) or placebo in a blinded fashion. There was a 30-min recovery period between the first and the second test and 60 min between the second and the third test. The rate-pressure product at 1-mm ST-segment depression (ischemic threshold) and the maximum ST-segment depression (STD) adjusted to the highest rate-pressure product common to the three tests were analyzed. In the placebo group, there was a significant increase in the ischemic threshold during the second and third test and a significant decrease in the maximum adjusted STD during the second test which was lost during the third test. This apparent adaptation to exercise-induced ischemia was not seen in the glibenclamide-treated patients. In the pinacidil-treated patients, there was a paradoxical decrease in ischemic threshold during the second test with no change in maximum adjusted STD which tended to be lower than in the placebo-treated patients on each exercise test. This study confirms that the warm-up phenomenon can be induced during repeated exercise testing. The blockade of this phenomenon by glibenclamide suggests that the ATP-sensitive potassium channels may be involved in this potential protective mechanism. At the same time, the paradoxical response in the pinacidil-treated patients flags a warning that drugs acting on the sarcolemmal ATP-sensitive potassium channels may have a direct effect on the ST-segment that may interfere with the interpretation of the electrocardiogram.
No takes yet. Share an insight, caveat, or question.
Lindhardt et al. (2005) conducted an RCT in Stable angina pectoris (n=31). Glibenclamide or Pinacidil vs. Placebo was evaluated on Rate-pressure product at 1-mm ST-segment depression (ischemic threshold) and maximum ST-segment depression. Glibenclamide blocked the exercise-induced adaptation (warm-up angina) seen with placebo, while pinacidil caused a paradoxical decrease in ischemic threshold.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Cardiology